United States · FDA National Drug Code directory
BLUDIGO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81284-315_2d60b6a4-17d2-4864-b01c-9862283da8de
- Product NDC
- 81284-315
- Form
- INJECTION
- Composition / generic term
- indigotindisulfonate sodium
- Labeler
- Provepharm Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220906
- Source listing expiry
- 20261231
Source-listed ingredients
- INDIGOTINDISULFONATE SODIUM — 8 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 AMPULE in 1 CARTON (81284-315-05) / 5 mL in 1 AMPULE (81284-315-00) · 81284-315-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →